key: cord-0945794-n2t2i9uq authors: Manti, Sara; Cuppari, Caterina; Lanzafame, Angela; Salpietro, Carmelo; Betta, Pasqua; Leonardi, Salvatore; Perez, Miriam K.; Piedimonte, Giovanni title: DETECTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AT BIRTH IN A NEWBORN WITH RESPIRATORY DISTRESS date: 2017-08-18 journal: Pediatric Pulmonology DOI: 10.1002/ppul.23775 sha: 7f34ce1224c44f67e9fe8df6fe938c9628c92f4a doc_id: 945794 cord_uid: n2t2i9uq Respiratory syncytial virus (RSV) is the most common respiratory pathogen in infants and young children. From the nasopharyngeal or conjunctival mucosa of infected individuals, RSV spreads to the lower respiratory tract causing acute bronchiolitis and pneumonia after an incubation period of 4 to 6 days. In addition to its well-documented tropism for the airway epithelium, it has been shown previously that RSV can also spread hematogenously and efficiently infect extrapulmonary tissues of human hosts. Furthermore, it has been shown in animal models that RSV can spread transplacentally from the respiratory tract of a pregnant mother to the lungs of the fetus. This report describes a documented case of neonatal RSV infection strongly suggestive of prenatal transmission of this infection in humans from an infected mother to her offspring. Respiratory syncytial virus (RSV), an enveloped, non-segmented, negative-sense RNA virus belonging to the Paramyxoviridae family, is the most common respiratory pathogen in infants and young children, 1 resulting in approximately 24 hospitalizations per 1000 infants and an estimated 66 000-199 000 annual deaths worldwide in children younger than 5 years, with 99% of these deaths occurring in developing countries. 2 After entering the host through the nasopharyngeal or conjunctival mucosa, RSV spreads to the lower respiratory tract where it can cause acute disease characterized by edema and necrosis of the respiratory mucosa leading to airflow obstruction. 3 The incubation period ranges from 2 to 8 days but usually is 4 to 6 days. 1 In addition to its well-documented tropism for the human airway epithelium, RSV is able to spread hematogenously from the primary site of infection to remote extra-pulmonary tissues, 4,5 particularly the bone marrow stromal cells that may provide the virus with an immunologically privileged sanctuary, and allow its persistence in latent state. 6 Expanding on these findings, RSV has been shown recently to spread across the rodent placenta from the respiratory tract of an infected dam to the lungs of the fetus. [7] [8] [9] However, so far vertical transmission of this virus has been demonstrated in animal models, but never in humans. Herein, we describe a case of RSV infection documented at birth in the peripheral blood of a human newborn with onset of severe respiratory distress immediately after delivery from a mother with serological and clinical evidence of RSV infection during pregnancy. showing that the same RSV strain used to infect pregnant rats was subsequently detected in 30% of fetuses exposed in utero, as well as in lung tissues from 40% of newborn rats and 25% of adult rats born from infected pregnant dams. 9 Importantly, prenatal RSV exposure modified the expression of genes encoding growth factors critical for development of the peripheral nervous system, particularly affecting the cholinergic innervation of the airways and leading to bronchial hyperreactivity. 16 The case described in this report may be the first clinical description of vertical transmission of RSV in a newborn, reproducing the experimental conditions used in Piedimonte's rodent model. 9 Indeed, the newborn's mother reported cough during the pregnancy, However, several studies have previously demonstrated that the IgA detected in neonatal blood is primarily of fetal origin. [21] [22] [23] [24] [25] [26] [27] In normal development, fetal IgA is either undetectable or rises very slowly during gestation and fetal levels at term remain approximately 1000 times lower than concentrations in the maternal circulation. 28 Secretory IgA is then transferred to the newborn by breastfeeding, 29 but our patient did not receive breast milk in the NICU. Thus, a positive IgG titer indicates that the fetus has "inherited" maternal antibodies, but positive IgA-especially at the high titers found in our patient (1:60) -together with positive IgM at birth suggest strongly that the fetus had been vertically infected. At any rate, these serology results were confirmed in our patient by the detection of clinically relevant amounts of RSV RNA. In addition, to exclude co-infections and/or super- More importantly, the possibility that RSV is transmitted vertically from mother to fetus has the potential of changing our strategies for the prevention and therapy of this highly prevalent infection and its The authors have declared no conflict of interest. Respiratory syncytial virus prevention and therapy: past, present, and future Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Respiratory syncytial virus in early infancy: circulating antibody and the severity of infection Central nervous system alterations caused by infection with the human respiratory syncytial virus Extrapulmonary manifestations of severe respiratory syncytial virus infection-a systematic review Respiratory syncytial virus infection in human bone marrow stromal cells Prenatal exposure to respiratory syncytial virus alters postnatal immunity and airway smooth muscle contractility during early-life reinfections Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs? Vertical transmission of respiratory syncytial virus modulates pre-and postnatal innervation and reactivity of rat airways Respiratory syncytial virus: the virus, the disease and the immune response The burden of respiratory syncytial virus infection in young children A hypothesis: antenatal sensitisation to respiratory syncytial virus in viral bronchiolitis Safety and immunogenicity of respiratory syncytial virus purified fusion protein 2 vaccine in pregnant women Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level The role of neurotrophins in inflammation and allergy Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection Vertical transmission of viruses Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction Efficacy of the placental barrier for immunoglobulins: correlations between maternal, paternal and fetal immunoglobulin levels Fetal immunoglobulin synthesis following maternal immunosuppression The effect of fetal age, birth weight, and sex on cord blood immunoglobulin values Production of alpha 1 and alpha 2 immunoglobulin heavy chains during fetal life Evolution of maternofetal transport of immunoglobulins during human pregnancy Transport of proteins across the human placenta Immunoglobulins in newborns, particularly in term SFD infants Ex vivo human placenta models: transport of immunoglobulin G and its subclasses The mother's immune system is a balanced threat to the foetus, turning to protection of the neonate Detection of respiratory syncytial virus (RSV) at birth in a newborn with respiratory distress